Your browser doesn't support javascript.
loading
Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma - Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center.
Momotow, Jesko; Goergen, Helen; Behringer, Karolin; Bröckelmann, Paul J; Borchmann, Sven; Tresckow, Bastian V; Kobe, Carsten; Engert, Andreas; Sasse, Stephanie.
Affiliation
  • Momotow J; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne.
  • Goergen H; German Hodgkin Study Group (GHSG).
  • Behringer K; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne.
  • Bröckelmann PJ; German Hodgkin Study Group (GHSG).
  • Borchmann S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne.
  • Tresckow BV; German Hodgkin Study Group (GHSG).
  • Kobe C; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne.
  • Engert A; German Hodgkin Study Group (GHSG).
  • Sasse S; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne.
Hemasphere ; 3(4): e293, 2019 10.
Article in En | MEDLINE | ID: mdl-31942546
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Hemasphere Year: 2019 Document type: Article Country of publication: United States